Comparing Study Between Concurrent Chemoradiation and New Combination Treatment in Cervical Cancer Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

824

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2013

Study Completion Date

June 30, 2018

Conditions
Cervical Cancer
Interventions
OTHER

Neoadjuvant chemotherapy followed by surgery

Cisplatin 50 mg/m2 (in the vein)on day 1 of each 23 day cycle plus gemcitabine 1000 mg/m2 (in the vein) on day 1 and day 8, for 3 cycles: until progression or unacceptable toxicity develops.

Trial Locations (1)

90110

RECRUITING

Gynecologic Oncology Unit, Department of Obstertrics and Gynecology, Faculty of medicine, Prince of Songkla University, Hat Yai

All Listed Sponsors
collaborator

National Research Council of Thailand

OTHER_GOV

collaborator

Clinical Research Collaborative Network

NETWORK

lead

Thai Gynecologic Oncology Collaborative Group

NETWORK